Skip to main content
. 2020 Oct 15;21(20):7621. doi: 10.3390/ijms21207621
APCs antigen-presenting cells
APOBEC apolipoprotein-B mRNA editing enzyme catalytic polypeptide-like
Bcl-xL B cell lymphoma-extra large
bTMB plasma-based tumor mutational burden
cCSCs circulating cancer stem-like cells
CPS combined positive score
CTCs circulating tumor cells
ctDNA circulating tumor DNA
CTLA-4 cytotoxic T lymphocyte antigen 4
dMMR mismatch repair deficiency
EBV Epstein-Barr virus
EpCAM Epithelial cell adhesion molecule
FDA Food and Drug Administration
GEP gene expression profile
HNSCC head and neck squamous cell carcinoma
HPV human papillomavirus
ICIs immune checkpoint inhibitors
IFN interferon
IS immunoscore
LAG-3 lymphocyte-activating gene 3
NIH National Institutes of Health
Mb megabase
MSI microsatellite instability
MSI-H high microsatellite instability
NK natural killer
OR odds ratio
OS overall survival
PD-1 programmed cell death protein-1
PD-L1 programmed death ligand-1
PFS progression-free survival
R/M HNSCC recurrent and metastatic HNSCC
SCC Squamous cell carcinoma
SOC standard of care
TCGA The Cancer Genome Atlas
TIGIT T cell immunoreceptor with Ig and ITIM domains
TIM-3 T cell immunoglobulin and mucin domain-containing protein 3
TMB tumor mutational burden
TME tumor microenvironment
TPS tumor proportion score
Tregs regulatory T cells